Back to Results
First PageMeta Content
Pediatrics / Intensive care medicine / Nitrogen metabolism / Neonatal intensive care unit / Nursing / Preterm birth / Nitric oxide / Hydrogen sulfide / Bronchopulmonary dysplasia / Chemistry / Medicine / Health


INHALED NITRIC OXIDE DATA PRESENTED AT EUROPEAN ACADEMY OF PEDIATRICS MEETING Clinton, NJ, October 25, 2008– Ikaria Holdings, Inc. today announced that results from its Phase III clinical trial - INOT27, nitric oxide f
Add to Reading List

Document Date: 2011-06-28 11:52:50

Open Document

File Size: 113,81 KB

Share Result on Facebook

City

Madison / Seattle / Nice / Port Allen / Paris / /

Company

Ikaria Holdings Inc. / /

Continent

Europe / /

Country

France / Japan / Canada / Australia / /

Event

FDA Phase / /

Facility

University of Pennsylvania / University of California / University of Paris / /

IndustryTerm

manufacturing facility / pharmaceuticals / treatment of bronchopulmonary disease / nitrogen gas / treatment of hypoxic respiratory failure / /

MedicalCondition

bronchopulmonary disease / long-term pulmonary outcome / respiratory distress syndrome / hypoxic respiratory failure / /

MedicalTreatment

continuous positive airway pressure / /

Organization

Denis Diderot Medical School / University of Paris / University of Pennsylvania / Division of Pediatric and Neonatal Intensive Care / FDA / University of California / San Francisco / INHALED NITRIC OXIDE DATA PRESENTED AT EUROPEAN ACADEMY OF PEDIATRICS MEETING Clinton / European Academy of Pediatrics / /

Person

Clinton / Denis Diderot / Roberta A. Ballard / Robert Debré / Jean-Christophe Mercier / /

Position

Professor of Pediatrics / lead researcher / Professor of Pediatrics and Obstetrics and Gynecology / Associate Professor / /

Product

INOmax / INOT27 / /

ProvinceOrState

Wisconsin / Pennsylvania / Louisiana / California / Washington / /

Region

Latin America / /

URL

www.ikaria.com / /

SocialTag